A Clinical Evaluation of the Safety and Effectiveness of the MitraClip System in the Treatment of Clinically Significant Functional Mitral Regurgitation

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 505 participants.

Also called NCT02444338

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 505 participants (enrolled count) (from the registry)
Sponsor
University Medical Center Goettingen (from the registry)
Registry
  • NCT NCT02444338
Other papers using this trial's data
  • Transcatheter Valve Repair in Heart Failure with Moderate to Severe Mitral Regurgitation The New England journal of medicine, 2024-11-14 DOI, PubMed 39216092

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Czechia, Denmark, Germany, Greece, Italy, Poland, Portugal, Spain, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02444338. Randomized; single masking; primary purpose treatment. Start 2015-03 (registry gives no type); primary completion 2024-04-19 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Clinical Evaluation of the Safety and Effectiveness of the MitraClip System in the Treatment of Clinically Significant Functional Mitral Regurgitation
Acronym
Reshape-HF2
Condition
Mitral Valve Insufficiency
Intervention (Device)
MitraClip
Intervention (Other)
standard of care
Lead sponsor
University Medical Center Goettingen (class: other)

Record details

Record id
cardio:ct-nct02444338
Content hash
f46c105218e283cf5df58ddf4d6a167839847dbf72c6292277de9af838b75f59